Prognostic value of single-nucleotide polymorphisms for extranodal natural killer/T-cell lymphoma: the identification of risk factors in the molecular era
- PMID: 34523265
- PMCID: PMC8626590
- DOI: 10.1002/cac2.12212
Prognostic value of single-nucleotide polymorphisms for extranodal natural killer/T-cell lymphoma: the identification of risk factors in the molecular era
Conflict of interest statement
The authors declare that they have no competing interests.
Comment on
-
A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma.Blood. 2021 Aug 12;138(6):452-463. doi: 10.1182/blood.2020010637. Blood. 2021. PMID: 33728448 Clinical Trial.
References
-
- Yamaguchi M, Suzuki R, Oguchi M. Advances in the treatment of extranodal NK/T‐cell lymphoma, nasal type. Blood. 2018;131(23):2528‐40. - PubMed
-
- Yang Y, Zhang YJ, Zhu Y, Cao JZ, Yuan ZY, Xu LM, et al. Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T‐cell lymphoma, nasal‐type: a multicenter study. Leukemia. 2015;29(7):1571‐7. - PubMed
-
- Chen SY, Yang Y, Qi SN, Wang Y, Hu C, He X, et al. Validation of nomogram‐revised risk index and comparison with other models for extranodal nasal‐type NK/T‐cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision‐making. Leukemia. 2021;35(1):130‐42. - PMC - PubMed
-
- Kim SJ, Yoon DH, Jaccard A, Chng WJ, Lim ST, Hong H, et al. A prognostic index for natural killer cell lymphoma after non‐anthracycline‐based treatment: a multicentre, retrospective analysis. Lancet Oncol. 2016;17(3):389‐400. - PubMed
-
- Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH, et al. Extranodal natural killer T‐cell lymphoma, nasal‐type: a prognostic model from a retrospective multicenter study. Journal of clinical oncology. 2006;24(4):612‐8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
